The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways.
| Autor: | Cardoso, Bruno A.1,2, Belo, Hélio1,2, Barata, João T.3, Almeida, António M.1,2 amalmeida@ipolisboa.min-saude.pt |
|---|---|
| Zdroj: | PLoS ONE. 12/1/2015, Vol. 10 Issue 12, p1-16. 16p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|